Racherla, K.S.; Dovalovsky, K.; Patel, M.; Harper, E.; Barnard, J.; Nasifuzzaman, S.M.; Smith, M.; Sikand, R.; Drinka, E.; Puri, N.
PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC. Cancers 2023, 15, 3461.
https://doi.org/10.3390/cancers15133461
AMA Style
Racherla KS, Dovalovsky K, Patel M, Harper E, Barnard J, Nasifuzzaman SM, Smith M, Sikand R, Drinka E, Puri N.
PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC. Cancers. 2023; 15(13):3461.
https://doi.org/10.3390/cancers15133461
Chicago/Turabian Style
Racherla, Kavya Sri, Katrina Dovalovsky, Meet Patel, Emma Harper, Jacob Barnard, S M Nasifuzzaman, Mason Smith, Riya Sikand, Eva Drinka, and Neelu Puri.
2023. "PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC" Cancers 15, no. 13: 3461.
https://doi.org/10.3390/cancers15133461
APA Style
Racherla, K. S., Dovalovsky, K., Patel, M., Harper, E., Barnard, J., Nasifuzzaman, S. M., Smith, M., Sikand, R., Drinka, E., & Puri, N.
(2023). PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC. Cancers, 15(13), 3461.
https://doi.org/10.3390/cancers15133461